Homestead Advisers Corp
Position in PRAX — Praxis Precision Medicines, Inc.
CIK 944804
Arlington, VA
Position in PRAX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,176,135
+$1,112,908 QoQ
Shares Held
6,500
+97.0% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#144
of 308 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Homestead Advisers Corp holds $101,557,390 across 6 Biotechnology names. PRAX ranks #2 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
1,657,242 | $92,921,558 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
This page
|
6,500 | $2,176,135 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
5,500 | $2,044,185 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
34,400 | $1,999,672 | |
| 5 | CYTK |
Cytokinetics Inc
|
23,200 | $1,976,408 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
5,900 | $439,432 |
All Filings in PRAX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,176,135 | 6,500 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,063,227 | 3,300 | Shares | Defined | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||